Mera Tilley, Senior Director, Translational Genetics, Foresite Capital
Mera Tilley is a genetic epidemiologist leading the creation of precision medicine-based biotechs. Before joining Foresite Labs in 2019, she did a stint in the start-up world leading translational genetic strategies at Goldfinch Bio, a Third Rock Ventures company. Prior to Goldfinch, she spent 6 years at Pfizer applying human genetics for drug target discovery and clinical development. Prior to Pfizer, she was at the National Human Genome Research Institute, where she developed new methods for analyzing rare variants in DNA sequence data to discover novel genetic causes of coronary artery disease. During her early career, she trained in a variety of fields, including molecular biology, bioinformatics, and science policy.